Mental Health

Your input is needed on a review considering esketamine for people with treatment-resistant depression.

Skills / interests: Patient and public input

Would you be interested in helping us with this research article focused on esketamine for people with treatment-resistant depression in adults?

 

I am looking for a patient or member of the public who would be willing to peer review this Cochrane systematic review “Esketamine for treatment-resistant depression in adults.”

 

When we say ‘patients and the public’, we mean patients and potential patients, carers, people who use health and social care services, and people or organizations that represent these groups.

 

We are interested if the language of the review, especially the language used in the Plain Language Summary (PLS), is accessible and if it feels relevant for those experiencing treatment-resistant depression in adults, so it will be helpful to patients and members of the public making healthcare decisions.

 

We welcome feedback on any aspect of the review, noting in particular a focus on the PLS section. Our aim is for this to be a manageable task and not overburden our reviewers.

 

If you are interested in providing peer review, please include your e-mail address in your response. This will allow us to confirm your enrolment in our editorial management system (called Editorial Manager) and ensure that you can receive the review assignment.

 

Thank you in advance for your consideration!

Ideal applicant

Someone with lived experience of treatment-resistant depression, including those who have used esketamine or other treatments, or caregivers or service users of mental health care for severe depression.

This task is no longer open for applications.